Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Weight-loss drug approved for heart problems in UK Weight-loss treatment Wegovy has been approved by the UK's medicines regulator, for reducing the risk of serious heart problems in overweight and obese people
Combination approaches remain largely experimental and require prescriber expertise
All prescribing decisions are made solely by licensed healthcare professionals after individualized medical assessment
The trial result that drew comparisons to surgery In TRIUMPH-1, Lillys pivotal obesity trial with 2,339 participants, people on the highest dose lost an average of 28.3 percent of their body weight over 80 weeks
These complementary effects on fat and muscle catabolism suggest that GLP-1 RAs may help preserve skeletal muscle integrity while concurrently improving metabolic efficiency in the context of obesity-related muscle dysfunction
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
